$ORRF

ORRSTOWN FINANCIAL SERVICES INC (ORRF): Results of Operations and Financial Condition

ORRSTOWN FINANCIAL SERVICES INC (ORRF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex9912026-q2earningsrelease.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE: Orrstown Financial Services, Inc. Reports Second Quarter 2026 Results • Net income of $21.2 million, or $1.09 per diluted share, for the three months ended June 30, 2026 compared to net

Original reporting
Published Jul 22, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ORRF
Neutral
medium confidence
Mentioned
$ORRF
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ORRFNeutralMed
01

Why it matters

Key trading inputs are the quarter’s earnings and margin trajectory, credit quality (nonaccrual ratio), balance-sheet growth (loans), capital/tangible book changes, and a specific subordinated-note redemption that affects future interest expense.

02

Market read

Traders can update near-term expectations for ORRF’s earnings power using the disclosed NIM, credit metrics, tangible book value, and the debt redemption mechanics.

03

What to watch

Deposit mix shifted toward lower-cost demand and money market, and nonaccruals improved to 0.58%. Those credit and funding details could outweigh the headline NIM decline for some valuation frameworks.

Relevance 7/10Novelty 6/10Timing: after-hours SEC 8-K filing for Q2 2026 results

Background

This SEC 8-K includes Orrstown Financial Services’ Q2 2026 results (Item 2.02) with an earnings release exhibit.

Company-level read

Ticker impact

$ORRFNeutralMedium confidence
Context

Orrstown Financial Services reported Q2 2026 net income of $21.2M, NIM 3.87%, and redeemed $31.0M subordinated notes on June 30, 2026.

Expected impact

Near-term bias likely neutral to slightly negative unless investors focus on tangible book value growth and the expected benefit from the redeemed notes.

Evidence & confidence

The filing provides multiple decision-relevant datapoints (earnings, NIM, nonaccrual ratio, loan growth, capital/tangible book, and a specific debt redemption) but no explicit forward guidance beyond qualitative statements.

Market effects

Regional bank read-through: redemption of subordinated debt and NIM sensitivity to amortization can influence how investors model earnings power.

Limited to the company’s footprint in Pennsylvania and surrounding markets; no broader regional banking shock indicated.

Low; this is a single-bank earnings and balance-sheet update with no cross-border or macro policy catalyst.

Counterpoint

Investors may discount the quarter-to-quarter NIM dip as largely accounting-driven (amortization of the redeemed notes’ fair value mark) and instead price the longer-run benefit of removing that subordinated cost.

Key entities

  • Orrstown Financial Services, Inc.

    NASDAQ-listed parent company of Orrstown Bank; reported Q2 2026 results and redeemed $31.0M subordinated notes.

  • Orrstown Bank

    Bank subsidiary referenced in the earnings release for loan, deposit, and liquidity metrics.

Related articles

$MRVLHighAI 8/10

Marvell Stock Had A Huge Year And Still Sits Well Below Its High

Marvell Technology (MRVL) stock rose 235.9% in the past year but has since pulled back. The company reported $8B in fiscal 2026 revenue and guides $12B and $18B for fiscal 2027 and 2028, respectively. Data centers contributed 79% of Q2 2027 revenue. Gross margins are expected to decline due to custom business growth, but operating margins are projected to improve. MRVL trades at ~20x trailing sales.

$LULUHighAI 9/10

Lululemon sinks after cutting forecast as revenue declines

Lululemon (LULU) shares fell 18% after the company reduced its revenue and profit outlook for 2026. Q2 revenue declined 4% to $2.4B, with comparable sales down 9%. The company now expects full-year revenue of $10.35B-$10.5B, a 5%-7% decrease. Incoming CEO Heidi O'Neill, a Nike veteran, will start next week.

$INODMed

Why Innodata Stock Tumbled by 10% Last Month

Innodata (INOD) reported Q2 revenue of $92.1M, up 58% YoY, and GAAP net income of $14.4M, beating estimates. Despite strong results, its stock fell 10% in August due to a new CEO appointment and a $300M stock offering. The company's reliance on a few key clients is a concern.

$LULUHighAI 8/10

Lululemon makes big cuts to one kind of store

Lululemon (LULU) reported a 4% revenue decline in Q2 2026, with comparable sales down 9%. The company lowered its full-year revenue guidance to $10.35B-$10.5B and earnings to $9.48-$9.73 per share. Lululemon plans to reduce pop-up stores from 65 to 40 by year-end, focusing on permanent locations with proven success. Shares dropped over 17% following the earnings report.

$SITMMed

SiTime (SITM) Is Up 9.7% After Q2 Beat And Renesas Deal Close Has The Bull Case Changed?

SiTime (SITM) reported Q2 2026 earnings and revenue growth exceeding expectations, driven by demand in communications, enterprise, and data center sectors. The company completed the acquisition of Renesas' timing business, expanding its portfolio. SiTime projects $2.3B revenue and $801.1M earnings by 2029, requiring 69% annual revenue growth. Analysts had projected 76.9% growth and $759.8M earnings by 2029. The acquisition and strong Q2 performance may influence SiTime's investment narrative, bu

$CBRSMedAI 8/10

Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It

Cerebras Systems reported Q2 adjusted revenue of $209.9M, up 103% YoY, with a $25.4B backlog driven by an OpenAI agreement. The company raised its full-year outlook to $880M-$890M. OpenAI's deal accounts for most of the backlog, with revenue recognition expected over several years. Cerebras' stock is down 44% from its 52-week high, trading at a market cap of ~$51B.